Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Results 1 - 20 of 224 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar JeffRossMD (< 20) Submitted: 10/30/2014 12:44:24 PM : Outperform Start Price: $58.26 BMY Score: -1.50

The biotech space is just heating up as new technologies are revolutionizing cancer and chronic disease processes.

Recs

0
Member Avatar mikeayu (< 20) Submitted: 10/14/2014 7:06:01 PM : Outperform Start Price: $48.36 BMY Score: +11.42

Huge upside from cancel drugs.

Recs

0
Member Avatar afewgoodstocks14 (< 20) Submitted: 10/1/2014 2:23:35 PM : Outperform Start Price: $50.52 BMY Score: +8.10

Div. (Yield) $1.44 (2.8%)

Recs

0
Member Avatar Herbstmd (55.17) Submitted: 8/22/2014 11:55:42 AM : Outperform Start Price: $49.68 BMY Score: +15.94

Developing great new cancer drugs called PD1, which may revolutionize cancer therapy.

Recs

0
Member Avatar Kenji94 (49.82) Submitted: 8/19/2014 1:29:19 AM : Underperform Start Price: $49.81 BMY Score: -14.90

There is a disconnection between price and fundamentals. I would like to own the company, but not at this price.

Recs

0
Member Avatar hydn (< 20) Submitted: 5/16/2014 10:28:57 AM : Outperform Start Price: $48.08 BMY Score: +13.19

Solid demand for ever improving products.

Recs

0
Member Avatar Johnybe (68.06) Submitted: 5/14/2014 9:46:28 PM : Outperform Start Price: $48.80 BMY Score: +12.35

strong player in this sector

Recs

0
Member Avatar DRGRNR (< 20) Submitted: 4/15/2014 7:52:17 PM : Outperform Start Price: $47.73 BMY Score: +13.19

I've owned BMY for 30 years, always a strong performer.

Recs

0
Member Avatar bassnman45 (36.50) Submitted: 1/2/2014 9:30:25 PM : Outperform Start Price: $20.86 BMY Score: +113.41

buy, hold long term and monitor

Recs

1
Member Avatar johnclanaro (< 20) Submitted: 10/28/2013 3:54:27 PM : Outperform Start Price: $50.68 BMY Score: +0.38

recent upgrade. good pipeline.

Recs

1
Member Avatar gilmomp1 (54.52) Submitted: 10/16/2013 9:38:21 PM : Outperform Start Price: $47.23 BMY Score: +5.53

I bought 100 shares of this company pre 1995 and now own 188 shares by reinvesting my dividends. Now that I'm nearing retirement that dividend looks pretty good!

Recs

1
Member Avatar nancytroi (< 20) Submitted: 10/2/2013 11:43:34 AM : Outperform Start Price: $45.37 BMY Score: +8.66

Continues finding new drugs to fight cancers

Recs

0
Member Avatar lg7691 (23.50) Submitted: 7/21/2013 1:34:10 PM : Outperform Start Price: $42.71 BMY Score: +17.20

7/21/13 44.19 drug stock

Recs

2
Member Avatar usubanas (99.67) Submitted: 5/15/2013 2:35:44 AM : Outperform Start Price: $40.43 BMY Score: +21.70

I'm buying this tomorrow because of PD-1

Recs

0
Member Avatar DonkeyJunk (43.00) Submitted: 5/5/2013 10:39:09 PM : Underperform Start Price: $38.41 BMY Score: -26.60

Stock with a PE of almost 50 in an on-average overvalued market due for a significant pullback. With a company this size, the increase in revenue would have to be astronomical to justify the price.

Recs

0
Member Avatar mfwatcher (< 20) Submitted: 2/9/2013 10:45:25 AM : Outperform Start Price: $34.99 BMY Score: +33.42

Product pipeline has it positioned to outperform its peers during the recovery period.

Recs

0
Member Avatar HP2006 (79.74) Submitted: 1/28/2013 12:57:26 AM : Outperform Start Price: $34.35 BMY Score: +35.15

pharma

Recs

0
Member Avatar jrgyardley (< 20) Submitted: 12/17/2012 6:45:49 PM : Outperform Start Price: $30.83 BMY Score: +48.69

Sector
Patent expirations

Recs

0
Member Avatar TMFHelical (99.05) Submitted: 11/13/2012 9:54:12 AM : Outperform Start Price: $29.99 BMY Score: +48.37

One of the leaders of an annual industry audit that looks at value creation in the biotech space.

http://caps.fool.com/Blogs/a-look-at-established-biotech/774287

Recs

0
Member Avatar getoffmyfoot (58.76) Submitted: 11/5/2012 11:37:46 PM : Outperform Start Price: $31.19 BMY Score: +44.84

Can dividend reinvestment factor into this pick? Love the yield.

Featured Broker Partners


Advertisement